Evaluation of Mycobacterium avium complex clarithromycin susceptibility testing using SLOMYCO sensititre panels and JustOne strips

Journal of Clinical Microbiology

Volumn 48, Issue 5, 2010, Pages 1749-1752

  Babady, N Esther ^a   Hall, Leslie ^a   Abbenyi, Adeline T ^a   Eisberner, Justin J ^a   Brown Elliott, Barbara A ^b   Pratt, Cody J ^a   McGlasson, Maria C ^b   Beierle, Keanan D ^b   Wohlfiel, Sherri L ^a   Deml, Sharon M ^a   Wallace Jr , Richard J ^b   Wengenack, Nancy L ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BROTH DILUTION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PRIORITY JOURNAL; RADIOMETRY;

ANTITUBERCULAR AGENTS; CLARITHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION;

MYCOBACTERIUM AVIUM COMPLEX;

EID: 77951783197     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01936-09     Document Type: Article

References (9)

1. Arend, S. M., D. van Soolingen, and T. H. Ottenhoff. 2009. Diagnosis and treatment of lung infection with nontuberculous mycobacteria. Curr. Opin. Pulm. Med. 15:201-208.
2. Chaisson, R. E., C. A. Benson, M. P. Dube, L. B. Heifets, J. A. Korvick, S. Elkin, T. Smith, J. C. Craft, and F. R. Sattler. 1994. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, doubleblind, dose-ranging study in patients with AIDS. Ann. Intern. Med. 121:905-911.
3. Dautzenberg, B., C. Truffot, S. Legris, M. C. Meyohas, H. C. Berlie, A. Mercat, S. Chevret, and J. Grosset. 1991. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am. Rev. Respir. Dis. 144:564-569.
4. Griffith, D. E., T. Aksamit, B. A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S. M. Holland, R. Horsburgh, G. Huitt, M. F. Iademarco, M. Iseman, K. Olivier, S. Ruoss, C. F. von Reyn, R. J. Wallace, Jr., and K. Winthrop. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367-416.
5. National Committee for Clinical Laboratory Standards. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
6. Ruf, B., D. Schurmann, H. Mauch, G. Jautzke, F. J. Fehrenbach, and H. D. Pohle. 1992. Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients. Infection 20:267-272.
7. Steingrube, V. A., J. L. Gibson, B. A. Brown, Y. Zhang, R. W. Wilson, M. Rajagopalan, and R. J. Wallace, Jr. 1995. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J. Clin. Microbiol. 33:149-153.
8. Telenti, A., F. Marchesi, M. Balz, F. Bally, E. C. Bottger, and T. Bodmer. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J. Clin. Microbiol. 31:175-178.
9. Waller, E. A., A. Roy, L. Brumble, A. Khoor, M. M. Johnson, and J. L. Garland. 2006. The expanding spectrum of Mycobacterium avium complexassociated pulmonary disease. Chest 130:1234-1241.